Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
26/05/2026 02:11
May 26 (Reuters) - Aroa Biosurgery Ltd ARX.AX: FY ADJUSTED EBITDA NZD 12.6 MILLION FY PRODUCT REVENUE NZD 103.9 MILLION FY PRODUCT GROSS MARGIN 85.5% AROA BIOSURGERY FY GROSS PROFIT NZD 88.8 MILLION AROA BIOSURGERY FY ADJUSTED OPERATING EXPENSES NZD 82.5 MILLION AROA BIOSURGERY SEES FY27 TOTAL REVENUE GUIDANCE OF NZ$115-125 MILLION AROA BIOSURGERY SEES FY27 NORMALISED EBITDA OF NZ$8-11 MILLION Further company coverage: ARX.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million